Wade Davis (@bioinfo44) profile picture
Joined June 2015
Wade Davis retweeted
We're excited to present our latest data at #IDWeek2021. Findings show that mcfDNA detected #fungal infections prior to onset of symptoms in children with #leukemia, also co-pathogen detection of #Aspergillus, #Mucorales, #PJP by the #KariusTest. Join us! https://nitter.cf/t.co/0UIdn9diyK
2
10
There's another job opening in my department! Please follow up with me if you are interested or know a good candidate! #hiring #jobs #bioinformatics #abbvie #pharma careers.abbvie.com/abbvie/jo…
2
3
Thank you @GovChristie and @jaketapper for being voices for dear Daniel Pearl. 19 yrs ago today, he was a gleeful expectant father. World: Pls raise your voice with your govt officials to help Ruth + @yudapearl realize #JusticeforDanielPearl. Supreme Court case restarts Jan 5.
13
61
5
417
Wade Davis retweeted
SRA plans to drop base quality. This would make resequencing data largely useless for var calling. There are better ways to save space: quality binning and CRAM. If you use reseq data from SRA, please voice yourself in this RFI (deadline in 2 weeks): datascience.nih.gov/sra-rfi-…
8
294
31
366
Excess deaths track reported COVID-19 deaths in Cook County, IL. The reported deaths, 860, are about 80% the actual cases, with this proportion trending towards 100%. We show data for Cook because, AFAIK, it is the only jurisdiction making up-to-date death registry data public.
2
10
3
31
If more scientists calculated confidence distributions, they would realise that a point estimate is a value in which you have zero confidence.
17
94
21
315
Our paper on using human genetics to predict drug program success is out! eurekalert.org/pub_releases/… journals.plos.org/plosgeneti…
8
37
2
69
This demonstrates beautifully the transformative value of studying consanguineous populations for finding human knockouts. Same discovery power with <1% the sample size.
This Post is from an account that no longer exists. Learn more
1
27
82
A way to see the meaninglessness of statements such as x > c vs. x <= c odds ratio = 1.6: OR=1.6 is heavily influenced by the number of subjects w/ x > 2c and x < c/2 and will change arbitrarily with patient inclusion criteria. Considers x=c+.001 hugely different from x=c-.001.
6
8